[Efficacy of remifentanil in anesthetic management for living-donor renal transplantation].
BACKGROUND
We used fentanyl and remifentanil in living-donor renal transplantation patients. So, we have compared both drugs in renal function.


METHODS
We used the volatile anesthetic sevoflurane as the base in 30 living-donor renal transplantation patients, dividing them into a remifentanil anesthesia group of 15 patients and a fentanyl anesthesia group of 15 patients, and compared their creatinine, BUN, and serum K values before surgery, and 1 day as well as 3 days after surgery.


RESULTS
The results showed improvement in their values, and there were no significant differences between the two groups.


CONCLUSIONS
Since more patients in the remifentanil group had adequate diuresis beginning immediately postoperatively without taking a diuretic, remifentanil appears to be a more suitable drug to use for anesthesia for living-donor renal transplantation.
Hashimoto
Kazuyoshi
K
Department of Anesthesiology, Uwajima Tokushukai General Hospital.
Ozawa
Yoshiki
Y
Tsurutani
Ai
A
Kobayashi
Tomoharu
T
Matsumoto
Shuichirou
S
Kojima
Keimei
K
Mannami
Makoto
M
D018686:Anesthetics, Intravenous / Q000494:pharmacology; D005260:Female; D005283:Fentanyl / Q000494:pharmacology; D006801:Humans; D007668:Kidney / Q000187:drug effects; D007677:Kidney Function Tests; D016030:Kidney Transplantation; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000494:pharmacology; D000077208:Remifentanil
D018686:Anesthetics, Intravenous; D010880:Piperidines; D000077208:Remifentanil; D005283:Fentanyl